Chairman Collins Exposes Valeant’s Drug Pricing Model, Reveals Harm Inflicted on Patients, Health Care System
Through its bipartisan investigation,
One of the witnesses invited by Chairman Collins revealed how these companies' actions inflict tangible harm on patients' health. For years,
"This kind of price manipulation and abuse of pricing has real consequences,"
"This does represent a market failure, and it represents a failure of the processes that we have in the federal government, at the
The Committee held the first hearing of the series on
Read this original document at: http://www.aging.senate.gov/press-releases/chairman-collins-exposes-valeants-drug-pricing-model-reveals-harm-inflicted-on-patients-health-care-system
Owners of Boston-Area Fried Chicken Restaurant Charged in Tax Fraud Scheme
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News